hrp0094fc1.3 | Adrenal | ESPE2021
Bacila Irina
, Lawrence Neil
, Alvi Sabah
, Cheetham Timothy
, Crowne Elizabeth
, Das Urmi
, Dattani Mehul
, Davies Justin H.
, Gevers Evelien
, Krone Ruth
, Kyriakou Andreas
, Patel Leena
, Randell Tabitha
, Ryan Fiona
, Ahmed Faisal S.
, Keevil Brian
, Taylor Norman
, Krone Nils
,
Introduction: Patients with congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency (21OHD) have specific plasma and urinary steroid patterns, with 11-oxygenatedC19 steroids established as key adrenal-specific androgens. Monitoring glucocorticoid (GC) replacement remains a challenge in the absence of reliable biomarkers.Aim: To reassess the urinary steroid profile of children with CAH in relation to plasma ...